MedTrace Logo

A Study for Patient With Chronic Low Back Pain

NCT00767806 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 401

Last updated 2010-10-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if duloxetine reduces the severity of chronic low back pain.

Conditions

  • Chronic Low Back Pain

Interventions

DRUG

Duloxetine

60 mg orally once daily for 12 weeks

DRUG

Placebo

Placebo once daily orally for 12 weeks

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • United States
  • Brazil
  • Germany
  • Netherlands
  • Poland
  • Russia
  • Spain

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767806 on ClinicalTrials.gov